General Information of Drug Off-Target (DOT) (ID: OTWIK6HT)

DOT Name Ninein-like protein (NINL)
Gene Name NINL
Related Disease
Mycoses ( )
Ankylosing spondylitis ( )
Ciliopathy ( )
Head-neck squamous cell carcinoma ( )
Leber congenital amaurosis ( )
Lung cancer ( )
Lung carcinoma ( )
Neoplasm ( )
Pathologic nystagmus ( )
Spondylitis ( )
Squamous cell carcinoma ( )
Usher syndrome ( )
Adult lymphoma ( )
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Lymphoma ( )
Pediatric lymphoma ( )
Classic Hodgkin lymphoma ( )
UniProt ID
NINL_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13499
Sequence
MDEEENHYVSQLREVYSSCDTTGTGFLDRQELTQLCLKLHLEQQLPVLLQTLLGNDHFAR
VNFEEFKEGFVAVLSSNAGVRPSDEDSSSLESAASSAIPPKYVNGSKWYGRRSRPELCDA
ATEARRVPEQQTQASLKSHLWRSASLESVESPKSDEEAESTKEAQNELFEAQGQLQTWDS
EDFGSPQKSCSPSFDTPESQIRGVWEELGVGSSGHLSEQELAVVCQSVGLQGLEKEELED
LFNKLDQDGDGKVSLEEFQLGLFSHEPALLLESSTRVKPSKAWSHYQVPEESGCHTTTTS
SLVSLCSSLRLFSSIDDGSGFAFPDQVLAMWTQEGIQNGREILQSLDFSVDEKVNLLELT
WALDNELMTVDSAVQQAALACYHQELSYQQGQVEQLARERDKARQDLERAEKRNLEFVKE
MDDCHSTLEQLTEKKIKHLEQGYRERLSLLRSEVEAERELFWEQAHRQRAALEWDVGRLQ
AEEAGLREKLTLALKENSRLQKEIVEVVEKLSDSERLALKLQKDLEFVLKDKLEPQSAEL
LAQEERFAAVLKEYELKCRDLQDRNDELQAELEGLWARLPKNRHSPSWSPDGRRRQLPGL
GPAGISFLGNSAPVSIETELMMEQVKEHYQDLRTQLETKVNYYEREIAALKRNFEKERKD
MEQARRREVSVLEGQKADLEELHEKSQEVIWGLQEQLQDTARGPEPEQMGLAPCCTQALC
GLALRHHSHLQQIRREAEAELSGELSGLGALPARRDLTLELEEPPQGPLPRGSQRSEQLE
LERALKLQPCASEKRAQMCVSLALEEEELELARGKRVDGPSLEAEMQALPKDGLVAGSGQ
EGTRGLLPLRPGCGERPLAWLAPGDGRESEEAAGAGPRRRQAQDTEATQSPAPAPAPASH
GPSERWSRMQPCGVDGDIVPKEPEPFGASAAGLEQPGARELPLLGTERDASQTQPRMWEP
PLRPAASCRGQAERLQAIQEERARSWSRGTQEQASEQQARAEGALEPGCHKHSVEVARRG
SLPSHLQLADPQGSWQEQLAAPEEGETKIALEREKDDMETKLLHLEDVVRALEKHVDLRE
NDRLEFHRLSEENTLLKNDLGRVRQELEAAESTHDAQRKEIEVLKKDKEKACSEMEVLNR
QNQNYKDQLSQLNVRVLQLGQEASTHQAQNEEHRVTIQMLTQSLEEVVRSGQQQSDQIQK
LRVELECLNQEHQSLQLPWSELTQTLEESQDQVQGAHLRLRQAQAQHLQEVRLVPQDRVA
ELHRLLSLQGEQARRRLDAQREEHEKQLKATEERVEEAEMILKNMEMLLQEKVDKLKEQF
EKNTKSDLLLKELYVENAHLVRALQATEEKQRGAEKQSRLLEEKVRALNKLVSRIAPAAL
SV
Function
Involved in the microtubule organization in interphase cells. Overexpression induces the fragmentation of the Golgi, and causes lysosomes to disperse toward the cell periphery; it also interferes with mitotic spindle assembly. Involved in vesicle transport in photoreceptor cells. May play a role in ovarian carcinogenesis.
Tissue Specificity
Expressed in KYSE-150 esophageal carcinoma, HeLa cervical carcinoma and U2OS osteosarcoma cells. Expression is regulated in a cell cycle-dependent manner and peaks during G2/M phase (at protein level). Expressed in fetal heart, skeletal muscle, liver, lung and cochlea, and in adult brain, testis, kidney and retina.
Reactome Pathway
Loss of Nlp from mitotic centrosomes (R-HSA-380259 )
Recruitment of mitotic centrosome proteins and complexes (R-HSA-380270 )
Loss of proteins required for interphase microtubule organization from the centrosome (R-HSA-380284 )
Recruitment of NuMA to mitotic centrosomes (R-HSA-380320 )
Anchoring of the basal body to the plasma membrane (R-HSA-5620912 )
AURKA Activation by TPX2 (R-HSA-8854518 )
Regulation of PLK1 Activity at G2/M Transition (R-HSA-2565942 )

Molecular Interaction Atlas (MIA) of This DOT

19 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Mycoses DIS9K7PB Definitive Biomarker [1]
Ankylosing spondylitis DISRC6IR Strong Biomarker [2]
Ciliopathy DIS10G4I Strong Biomarker [3]
Head-neck squamous cell carcinoma DISF7P24 Strong Altered Expression [4]
Leber congenital amaurosis DISMGH8F Strong Biomarker [5]
Lung cancer DISCM4YA Strong Biomarker [6]
Lung carcinoma DISTR26C Strong Biomarker [6]
Neoplasm DISZKGEW Strong Biomarker [7]
Pathologic nystagmus DIS1QSPO Strong Biomarker [8]
Spondylitis DIS3HV6E Strong Biomarker [2]
Squamous cell carcinoma DISQVIFL Strong Altered Expression [4]
Usher syndrome DIS9YIS7 Strong Biomarker [5]
Adult lymphoma DISK8IZR moderate Biomarker [9]
Advanced cancer DISAT1Z9 moderate Biomarker [9]
Breast cancer DIS7DPX1 moderate Biomarker [10]
Breast carcinoma DIS2UE88 moderate Biomarker [10]
Lymphoma DISN6V4S moderate Biomarker [9]
Pediatric lymphoma DIS51BK2 moderate Biomarker [9]
Classic Hodgkin lymphoma DISV1LU6 Limited Genetic Variation [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 19 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Ninein-like protein (NINL). [12]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Ninein-like protein (NINL). [17]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Ninein-like protein (NINL). [13]
Methotrexate DM2TEOL Approved Methotrexate increases the expression of Ninein-like protein (NINL). [14]
Resveratrol DM3RWXL Phase 3 Resveratrol decreases the expression of Ninein-like protein (NINL). [15]
Tocopherol DMBIJZ6 Phase 2 Tocopherol decreases the expression of Ninein-like protein (NINL). [16]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of Ninein-like protein (NINL). [18]
Coumestrol DM40TBU Investigative Coumestrol decreases the expression of Ninein-like protein (NINL). [15]
cinnamaldehyde DMZDUXG Investigative cinnamaldehyde increases the expression of Ninein-like protein (NINL). [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 An Antimicrobial Peptide and Its Neuronal Receptor Regulate Dendrite Degeneration in Aging and Infection.Neuron. 2018 Jan 3;97(1):125-138.e5. doi: 10.1016/j.neuron.2017.12.001.
2 Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records.Rheumatology (Oxford). 2020 May 1;59(5):1059-1065. doi: 10.1093/rheumatology/kez375.
3 The Ciliopathy Protein CC2D2A Associates with NINL and Functions in RAB8-MICAL3-Regulated Vesicle Trafficking.PLoS Genet. 2015 Oct 20;11(10):e1005575. doi: 10.1371/journal.pgen.1005575. eCollection 2015 Oct.
4 Ninein-like protein is overexpressed in head and neck squamous cell carcinoma and contributes to cancer growth and resistance to apoptosis.Oncol Rep. 2009 Oct;22(4):789-98. doi: 10.3892/or_00000501.
5 Usher syndrome and Leber congenital amaurosis are molecularly linked via a novel isoform of the centrosomal ninein-like protein.Hum Mol Genet. 2009 Jan 1;18(1):51-64. doi: 10.1093/hmg/ddn312. Epub 2008 Sep 30.
6 Profiling Lung Cancer Patients Using Electronic Health Records.J Med Syst. 2018 May 31;42(7):126. doi: 10.1007/s10916-018-0975-9.
7 Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice.J Clin Invest. 2010 Feb;120(2):498-507. doi: 10.1172/JCI39447. Epub 2010 Jan 19.
8 Phenotype of three consanguineous Tunisian families with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 gene.Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1104-12. doi: 10.1007/s00417-005-0096-2. Epub 2006 Feb 28.
9 The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis.Br J Cancer. 2011 May 10;104(10):1523-8. doi: 10.1038/bjc.2011.130. Epub 2011 Apr 19.
10 Effects of the ninein-like protein centrosomal protein on breast cancer cell invasion and migration.Mol Med Rep. 2015 Aug;12(2):1659-64. doi: 10.3892/mmr.2015.3650. Epub 2015 Apr 20.
11 Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.Leuk Lymphoma. 2004 Mar;45(3):423-31. doi: 10.1080/10428190310001593166.
12 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
13 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
14 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
15 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
16 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
17 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
18 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
19 Comparative DNA microarray analysis of human monocyte derived dendritic cells and MUTZ-3 cells exposed to the moderate skin sensitizer cinnamaldehyde. Toxicol Appl Pharmacol. 2009 Sep 15;239(3):273-83.